Fall 2023
By Colleen Sullivan
Ovarian cancer is often difficult to treat at later stages and difficult to detect at earlier stages. With a $100,000 grant, the Minnesota Ovarian Cancer Alliance is supporting research at Dana-Farber into the development of an ultrasensitive blood test to detect ovarian cancer at its earliest, and most treatable, stages.